Bionano reiterates $31M-$33M 2026 revenue guidance while targeting adjusted EBITDA neutrality by end of 2027
Open the sourceReported by Seeking Alpha, seekingalpha.com, 10 November 2026
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.